eXoZymes biomanufacturing breakthrough: From concept to gram-scale NCT in only 5 months
press releaseinvestornutraceuticalsvideoscience
eXoZymes biomanufacturing breakthrough: From concept to gram-scale NCT in only 5 monthsJuly 22, 2025
World Bio Markets: AI and Machine Learning - The Silver Bullet we Must Not Dodge
press clippingsvideo
World Bio Markets: AI and Machine Learning - The Silver Bullet we Must Not DodgeJuly 2, 2025
Dr. Paul Opgenorth
press releaseinvestornutraceuticalsmedicinescience
eXoZymes selected as core industry partner in $9M NSF-funded initiative to advance modular cell-free biomanufacturingJune 26, 2025
Chris Marlett, MDB Capital
investorpress clippingsvideo
Slack Capital interview: Chris Marlett, Chairman of the BoardMay 22, 2025
Slack Capital interview: Damien Perriman, CCO
investorpress clippingsvideo
Slack Capital interview: Damien Perriman, CCOMay 20, 2025
Michael Heltzen & Erum Azeez Khan
heltzenpress releaseinvestorpress clippings
Podcast: eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on 'Grow Everything'May 16, 2025
Tyler Korman
investorpress clippingsvideo
Slack Capital interview: Tyler Korman, VP of ResearchMay 15, 2025
Transcript: eXoZymes 1st quarter 2025 and NCTx subsidiary update
investor
Transcript: eXoZymes 1st quarter 2025 and NCTx subsidiary updateMay 14, 2025
Slack Capital: EXOZ investment report and CEO interview
heltzeninvestorpress clippingsvideo
Slack Capital: EXOZ investment report and CEO interviewMay 13, 2025
eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST today
press releaseinvestor
eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST todayMay 12, 2025
Previous page
Page 5 of 11
Next page